Theolytics
Pre-clinicalBreaking the Barriers to Solid Tumours with Groundbreaking Oncolytic Immunotherapy. Everyone should have access to innovative therapies that represent the promise of lasting cures. Theolytics is a biotech company working to transform patients’ lives, through world leading science, with a great team.
Founded
2017
Focus
Viral Technology
About
Breaking the Barriers to Solid Tumours with Groundbreaking Oncolytic Immunotherapy. Everyone should have access to innovative therapies that represent the promise of lasting cures. Theolytics is a biotech company working to transform patients’ lives, through world leading science, with a great team.
Funding History
2Total raised: $13.8M
Series A$10MEpidarex CapitalJul 15, 2021
Seed$3.8MOxford Sciences InnovationOct 15, 2019
Company Info
TypePrivate
Founded2017
LocationOxford, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile